Literature DB >> 27358466

Development of a Real-Time PCR Protocol Requiring Minimal Handling for Detection of Vancomycin-Resistant Enterococci with the Fully Automated BD Max System.

Alexander H Dalpke1, Marjeta Hofko2, Stefan Zimmermann2.   

Abstract

Vancomycin-resistant enterococci (VRE) are an important cause of health care-associated infections, resulting in significant mortality and a significant economic burden in hospitals. Active surveillance for at-risk populations contributes to the prevention of infections with VRE. The availability of a combination of automation and molecular detection procedures for rapid screening would be beneficial. Here, we report on the development of a laboratory-developed PCR for detection of VRE which runs on the fully automated Becton Dickinson (BD) Max platform, which combines DNA extraction, PCR setup, and real-time PCR amplification. We evaluated two protocols: one using a liquid master mix and the other employing commercially ordered dry-down reagents. The BD Max VRE PCR was evaluated in two rounds with 86 and 61 rectal elution swab (eSwab) samples, and the results were compared to the culture results. The sensitivities of the different PCR formats were 84 to 100% for vanA and 83.7 to 100% for vanB; specificities were 96.8 to 100% for vanA and 81.8 to 97% for vanB The use of dry-down reagents and the ExK DNA-2 kit for extraction showed that the samples were less inhibited (3.3%) than they were by the use of the liquid master mix (14.8%). Adoption of a cutoff threshold cycle of 35 for discrimination of vanB-positive samples allowed an increase of specificity to 87.9%. The performance of the BD Max VRE assay equaled that of the BD GeneOhm VanR assay, which was run in parallel. The use of dry-down reagents simplifies the assay and omits any need to handle liquid PCR reagents.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27358466      PMCID: PMC5005484          DOI: 10.1128/JCM.00768-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  INCREASED INFECTION RATES IN HEAVY NASAL CARRIERS OF COAGULASE-POSITIVE STAPHYLOCOCCI.

Authors:  A WHITE
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1963

2.  Complementary use of MALDI-TOF MS and real-time PCR-melt curve analysis for rapid identification of methicillin-resistant staphylococci and VRE.

Authors:  Wai-Sing Chan; Tsz-Ming Chan; Tsz-Wan Lai; Jasper Fuk-Woo Chan; Raymond Wai-Man Lai; Christopher Koon-Chi Lai; Bone Siu-Fai Tang
Journal:  J Antimicrob Chemother       Date:  2014-10-21       Impact factor: 5.790

Review 3.  The rise of the Enterococcus: beyond vancomycin resistance.

Authors:  Cesar A Arias; Barbara E Murray
Journal:  Nat Rev Microbiol       Date:  2012-03-16       Impact factor: 60.633

4.  Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii on the fully automated BD MAX platform.

Authors:  Alexander H Dalpke; Marjeta Hofko; Stefan Zimmermann
Journal:  J Clin Microbiol       Date:  2013-05-15       Impact factor: 5.948

Review 5.  Controlling the spread of vancomycin-resistant enterococci. Is active screening worthwhile?

Authors:  H Humphreys
Journal:  J Hosp Infect       Date:  2014-09-23       Impact factor: 3.926

6.  A study of carriers of Staphylococcus aureus with special regard to quantitative bacterial estimations.

Authors:  C O Solberg
Journal:  Acta Med Scand Suppl       Date:  1965

7.  Reconsidering contact precautions for endemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.

Authors:  Daniel J Morgan; Rekha Murthy; L Silvia Munoz-Price; Marsha Barnden; Bernard C Camins; B Lynn Johnston; Zachary Rubin; Kaede V Sullivan; Andi L Shane; E Patchen Dellinger; Mark E Rupp; Gonzalo Bearman
Journal:  Infect Control Hosp Epidemiol       Date:  2015-07-03       Impact factor: 3.254

8.  Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study.

Authors:  Shelly A McNeil; Preeti N Malani; Carol E Chenoweth; Robert J Fontana; John C Magee; Jeffrey D Punch; Monica L Mackin; Carol A Kauffman
Journal:  Clin Infect Dis       Date:  2005-12-12       Impact factor: 9.079

9.  Prospective, multicenter evaluation of the BD GeneOhm VanR assay for direct, rapid detection of vancomycin-resistant Enterococcus species in perianal and rectal specimens.

Authors:  Elena A Usacheva; Christine C Ginocchio; Margie Morgan; Geronimo Maglanoc; Maitry S Mehta; Sebastien Tremblay; Tobi B Karchmer; Lance R Peterson
Journal:  Am J Clin Pathol       Date:  2010-08       Impact factor: 2.493

10.  Low risk of apparent transmission of vancomycin-resistant Enterococci from bacteraemic patients to hospitalized contacts.

Authors:  Nico T Mutters; Russell J Brooke; Uwe Frank; Klaus Heeg
Journal:  Am J Infect Control       Date:  2013-02-28       Impact factor: 2.918

View more
  2 in total

1.  Shorter Incubation Times for Detecting Multi-drug Resistant Bacteria in Patient Samples: Defining Early Imaging Time Points Using Growth Kinetics and Total Laboratory Automation.

Authors:  Irene Burckhardt; Katharina Last; Stefan Zimmermann
Journal:  Ann Lab Med       Date:  2019-01       Impact factor: 3.464

2.  Challenges in interpretation of WGS and epidemiological data to investigate nosocomial transmission of vancomycin-resistant Enterococcus faecium in an endemic region: incorporation of patient movement network and admission screening.

Authors:  Vanessa Eichel; Sabrina Klein; Carolin Bootsveld; Uwe Frank; Klaus Heeg; Sébastien Boutin; Dennis Nurjadi
Journal:  J Antimicrob Chemother       Date:  2020-07-01       Impact factor: 5.790

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.